EHC/LinkedIn
Feb 15, 2026, 10:52
Awareness and Research on Factor V Deficiency Are Critical – EHC
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor V Deficiency
Nosebleeds that won’t stop. Bruises from nowhere.
Bleeding that just keeps going.
For people with this rare clotting disorder, these aren’t occasional issues—they’re part of life.
The condition can affect anyone at any age, but knowing the signs matters.
Right now, treatment options are limited, which is why awareness and research are so critical.
Want to learn more?
On the ERIN Focus Area page on our EHC Community website, you can find relevant webinars, podcasts, and publications.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT
-
Oct 9, 2026, 07:00Danny Reardon: Closing the Global Awareness Gap on Blood Clots
-
Oct 9, 2026, 00:54Mary Catherine Moffett: Advancing Advocacy Together – Highlights from the Sanofi Bleeding Disorders Summit